World First: H-UKR 0% Clinker Cement Obtains Technical Assessment (ATec) for Wind Turbine Foundations
Hoffmann Green Cement Technologies (ISIN: FR0013451044, Ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonation of the construction sector that designs and markets innovative cold produced, clinker-free cements, today announces that it has obtained a Technical Assessment (ATec) validating the use of its H-UKR decarbonized cement for wind turbine foundations. This unprecedented recognition, a world first for a 0% clinker cement, certifies that the H-UKR solution meets the highest standards of sustainability, safety, and performance for particularly rigorous applications such as wind power.
A strategic step towards new markets
This certification marks another key milestone for Hoffmann Green, enabling it to further accelerate its growth in the renewable energy market from 2026 and beyond. Obtaining this ATec certification paves the way for new commercial opportunities in this sector, strengthening its insurability with project owners and construction professionals.
Wind power is a high-potential market where each foundation pour requires 600 to 800 m3 of concrete. This validation is fully in line with Hoffmann Green's diversification strategy, particularly towards large-scale projects in the renewable energy sector.
Key technical and regulatory recognition
This Technical Assessment, issued by the CCFAT (Commission in Charge of Formulating Technical Assessments) with technical support from the CSTB, is the result of 18 months of work by Hoffmann Green's Evaluation and Quality Department. More complex than a building foundation, a wind turbine foundation must withstand concrete damage (fatigue) caused by continuous exposure to wind and vibrations throughout the wind turbine's lifetime. H-UKR cement has been tested and proven to withstand more than 1 million compressions without any loss of mechanical performance.
Julien BLANCHARD and David HOFFMANN, Co-founders of Hoffmann Green Cement Technologies, say: “Obtaining this Technical Assessment for a 0% clinker cement in an application as rigorous as wind turbine foundations marks a key milestone for Hoffmann Green. It confirms the reliability of our technologies in large-scale projects and enables us to accelerate our development in the renewable energy market from 2026 and beyond.”
ABOUT HOFFMANN GREEN CEMENT TECHNOLOGIES
For further information : www.ciments-hoffmann.fr/
View source version on businesswire.com: https://www.businesswire.com/news/home/20251021988630/en/
Contacts
Hoffmann Green
* Pierre-Emmanuel Favre
* Chief Financial Officer
* finances@ciments-hoffmann.fr
* 02 51 460 600
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Paymentology Launches PayCredit to Power Credit Innovation for Digital Banks and Fintechs22.10.2025 11:00:00 EEST | Press release
Paymentology, the leading global issuer-processor, has launched PayCredit, an advanced credit ledger platform designed to help financial institutions deliver tailored, feature rich credit products at speed, overcoming the limitations of legacy and core banking systems. Amid rising demand for flexible financial payment tools, credit cards remain a critical instrument for enabling consumer spending, managing cash flow, and deepening customer loyalty. Yet many legacy credit systems lack the flexibility to meet the expectations of today's consumers, who demand a combination of both revolving and instalment credit to help them better manage their money, whilst many modern ledgers are retrofitted from a debit architecture and struggle to provide credit processing. PayCredit was developed from the ground up with credit billing cycles and logic at its core, making it easier for issuers to build products that reflect real-world behaviours, from revolving balances to instalments and Buy Now, Pay
Infrastructure Capital Advisors Expands its Offerings into European Markets With Launch of Preferred Income UCITS ETF (PFFI) & Declares The Fund’s First Dividend22.10.2025 11:00:00 EEST | Press release
Infrastructure Capital Advisors (“Infrastructure Capital”), a leading provider of investment management solutions designed to meet the needs of income-focused investors, is celebrating the expansion of its offerings into Europe with the launch of the Infrastructure Capital Preferred Income UCITS ETF (PFFI). This actively managed ETF, which was listed in September, seeks to produce diversified income by targeting high yield income investments by predominately focusing on preferred stocks. Today,PFFI is also declaring its first dividend of $0.1335 per share ($1.602 per share on an annualized basis). The dividend will be paid on November 3, 2025 to shareholders of record as of the close of business on October 29, 2025. “We are thrilled to offer investors across a range of global markets the opportunity to benefit from our team’s active management process applied to preferred and income securities as we identify and capitalize on market inefficiencies,” said Jay Hatfield, CEO of Infrastruc
Locus Robotics Reports Record Growth Achieving 6 Billion Picks in Fastest Time Yet22.10.2025 11:00:00 EEST | Press release
Locus Robotics, the global leader in AI-driven, mobile warehouse automation, today announced its strongest growth over the past two quarters, reflecting accelerating industry adoption of Physical AI, seamlessly fusing intelligent robotics and real-world execution. Driven by surging implementations and faster time-to-value for customers, Locus Robotics recently surpassed 6 billion picks worldwide, with the last billion in just 24 weeks—the fastest pace in its history. “Our growth is driven by our customers’ success,” said Rick Faulk, CEO of Locus Robotics. “Retailers, 3PLs, and healthcare providers are seeing measurable impact faster than ever—scaling productivity in weeks, not months. Staples Canada, for example, hit one million picks just 70 days after going live, proving the immediate ROI our platform delivers.” So far this year, Locus Robotics has seen 30–40% year-over-year volume growth, with throughput reaching 200–300 units picked per second — roughly 45 million picks per week. L
Smartstream and ActiveViam Collaborate to Meet Demands for Collateral Optimisation22.10.2025 10:55:00 EEST | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces the partnership with ActiveViam, a global provider of advanced data analytics and decision-making solutions for financial services – together the two companies will provide immediate ROI for collateral management optimisation, for clients in treasury and capital markets. This collaboration connects two technologies, Smartstream’s Smart Collateral with ActiveViam’s Atoti Collateral Optimisation solution. The result is an efficient, streamlined and cost-effective solution for optimising and allocating cheaper-to-deliver assets, whilst reducing reliance on expensive liquidity buffers. The partnership provides a comprehensive, and modular collateral management workflow for financial institutions. This powerful combination future-proofs clients and enables them to make more efficient use of their cash and non-cash collateral inventory in a timely manner. Roland Brandli
Global Registry Data Show Meaningful Overall Survival Benefit in Patients with Advanced Cutaneous T-cell Lymphoma (CTCL) treated with POTELIGEO (mogamulizumab)22.10.2025 10:30:00 EEST | Press release
Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, and the University Hospitals Birmingham NHS Foundation Trust, today announced new overall survival (OS) insights from the PROCLIPI (PROgnostic Cutaneous Lymphoma International Prognostic Index) Study aligning with previous findings that suggest mogamulizumab may offer meaningful OS benefit for patients living with mycosis fungoides (MF) and Sézary syndrome (SS), two rare conditions and subtypes of cutaneous T-cell lymphoma (CTCL).2 Key findings2: For patients with advanced-stage MF and SS (n=371), the median overall survival from the onset of treatment was higher for patients treated with mogamulizumab (n=72) at 64 months compared with those not receiving mogamulizumab (n=175) at 54 months (p<0.01). Patients treated with mogamulizumab showed a trend toward improved OS compared to those not receiving mogamulizumab across risk
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom